Engineered Microbial Pathways for Renewable Terephthalate Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing terephthalate (PTA) are costly and rely on petrochemical sources, with limited biosynthetic pathways available for renewable production due to the irreversible nature of monooxygenases involved in bacterial degradation.
Innovation Solution
Design and production of non-naturally occurring microbial organisms with engineered metabolic pathways to biosynthesize p-toluate and terephthalate from carbohydrate feedstocks, utilizing enzymes like 2-dehydro-3-deoxyphosphoheptonate synthase and shikimate pathway enzymes to convert (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate to p-toluate and subsequently to terephthalate.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If monooxygenases are used for bacterial degradation of aromatic compounds, then degradation capability is achieved, but biosynthetic capability is lost due to irreversible reaction direction
Solution Approach 1:
The patent applies reverse engineering to the monooxygenase pathway by introducing enzymes that catalyze reactions in the opposite direction of natural degradation. Specifically, it uses p-toluate synthase to convert shikimic acid derivatives to p-toluate, and terephthalate synthase to convert p-toluate to terephthalate, thereby inverting the natural degradative pathway into a biosynthetic route.
Solution Approach 2:
The patent introduces p-toluate as an intermediate compound that bridges the shikimate pathway and terephthalate production. The engineered pathway uses shikimic acid as a starting material, converts it to p-toluate through p-toluate synthase, and then to terephthalate through terephthalate synthase, creating a multi-step intermediary pathway that enables renewable production.
2Productivity
If petrochemical oxidation processes are used for PTA production, then production scale is achieved, but cost-effectiveness and renewability are reduced
Solution Approach 1:
The patent employs engineered microorganisms that autonomously perform the biosynthesis of terephthalate from renewable carbohydrate feedstocks through their metabolic pathways. The microorganisms self-convert sugars to shikimic acid, then to p-toluate, and finally to terephthalate, eliminating the need for expensive petrochemical feedstocks and high-temperature oxidation processes.
Solution Approach 2:
The patent fundamentally changes the production parameters by shifting from high-temperature chemical oxidation (Mid Century Process) to mild physiological temperature biological synthesis. It replaces petrochemical para-xylene feedstock with renewable carbohydrate feedstocks, and uses engineered enzymatic pathways instead of cobalt/manganese catalyst systems, thereby reducing energy consumption and manufacturing costs.
3Manufacturing precision
If conventional p-xylene oxidation is used for PTA production, then product purity is achieved, but environmental sustainability is compromised
Solution Approach 1:
The patent converts the harmful dependence on petrochemical resources and high-energy oxidation processes into a beneficial renewable biological system. By engineering microorganisms to produce terephthalate from sugars through the shikimate pathway, it eliminates the need for para-xylene extraction from petroleum and high-temperature oxidation, thereby converting an environmentally harmful process into a sustainable one while maintaining product purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the cost-effective, renewable production of commercial quantities of p-toluate and terephthalate, overcoming the limitations of existing technologies by using engineered microbial organisms to convert carbohydrate feedstocks into these valuable compounds.
Implementation Method 1
utilizing enzymes like 2-dehydro-3-deoxyphosphoheptonate synthase and shikimate pathway enzymes to convert (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate to p-toluate
Implementation Method 2
non-naturally occurring microbial organisms with engineered metabolic pathways to biosynthesize p-toluate and terephthalate from carbohydrate feedstocks
Data Source
AI summary
The invention provides non-naturally occurring microbial organisms having a (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate pathway, p-toluate pathway, and/or terephthalate pathway. The invention additionally provides methods of using such organisms to produce (2-hydroxy-3-methyl-4-oxobutoxy)phosphonate pathway, p-toluate pathway or terephthalate pathway.